CN Patent

CN1893938A — 普瑞巴林组合物

Assigned to Pfizer Inc · Expires 2007-01-10 · 19y expired

What this patent protects

本发明提供一种化学和物理学稳定的、可口服给药的含普瑞巴林的水性药物组合物。该液体组合物包括至少一种防腐剂、至少一种矫味剂、以及可选的粘度调节剂。该液体药物组合物的pH至少为5.5但不超过7.0。

USPTO Abstract

本发明提供一种化学和物理学稳定的、可口服给药的含普瑞巴林的水性药物组合物。该液体组合物包括至少一种防腐剂、至少一种矫味剂、以及可选的粘度调节剂。该液体药物组合物的pH至少为5.5但不超过7.0。

Drugs covered by this patent

Patent Metadata

Patent number: CN1893938A
Jurisdiction: CN
Classification: —
Expires: 2007-01-10
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.